Sepsis Recognition and Management Gaps in Hospitals: A Post Hoc Analysis of a Subset of Data from the European Sepsis Care Survey Authors: Jakub Śmiechowicz, Christian S Scheer, Joanna Bartczak, Alicja Bartkowska-Śniatkowska, Katarzyna Baścik, Sławomir L Czaban, Piotr F Czempik, Wojciech Dąbrowski, Rafał Gałuszka, Maciej Gawor, Janusz Gruszczyk, Ludmiła Hasak, Jarosław Janc, Mateusz Jaworski, Jarosław Luboński, Małgorzata Mikaszewska-Sokolewicz, Tomasz Musiuk, Piotr Smuszkiewicz, Karina Stefańska-Wronka, Michał Śpiewak, Renata Szmigielska, Mariola Tałałaj, Łukasz Tkaczyk, Witold Wasiak, Rafał Wójtowicz, Magdalena Wujtewicz, Joanna Zorska, Barbara Adamik Published: 2026 ABSTRACT AbstractIntroductionSepsis is a life-threatening condition and its management should be a hospital priority. The European Sepsis Care Survey (ESCS) investigated the implementation of guideline recommendations and the availability of infrastructure for sepsis care across Europe. Our objective was to provide a country‑level baseline assessment of sepsis care in hospitals and to identify deficiencies in sepsis recognition and management.MethodsData from 55 hospitals located in Poland were analyzed regarding sepsis definitions, screening, management, infrastructure, and quality improvement programs (QIPs) in emergency departments (EDs), wards, and intensive care units (ICUs).ResultsSepsis-3 criteria were applied in 44% of hospitals. Sepsis screening and standardized management were used in 27% and 38.2% of EDs, 21% and 30.8% of wards, and 62% and 86.7% of ICUs, respectively. QIPs were present in 37% of hospitals, yet regular sepsis training across departments was reported by only 6.6%. In hospitals with QIPs, key indicators of sepsis care were monitored more frequently, including sepsis cases (76.5% versus 41.4%), mortality (70.6% versus 20.7%), time-to-antibiotics (29.4% versus 0%), bundle compliance (35.3% versus 0%), and also antibiotic stewardship (100% versus 58.6%) (all p < 0.05). Computed tomography (CT) or magnetic resonance imaging (MRI) was available 24 h a day in 94.2% of hospitals. Surgical source control was available 24 h a day in 92.7% of hospitals. Source control by interventional radiology was available in 34.5% of hospitals. Point-of-care lactate testing was available in 80% of emergency departments. Hospital guidelines for antimicrobial therapy in patients with sepsis were present in 65.5% of hospitals.ConclusionsOur study provides a country‑level baseline assessment of sepsis care in hospitals. Overall, adherence to established guidelines for sepsis recognition and management remains low and demands urgent improvement. Hospitals that implemented quality improvement programs demonstrated significantly higher compliance with these guidelines. Strengthening institutional support, establishing structured sepsis programs, and adopting systematic quality improvement approaches are essential to advancing sepsis care.Trial RegistrationClinicalTrials.gov identifier, NCT05059808.Graphical Abstract Keywords: Antimicrobial stewardship, Emergency department, Intensive care unit, Quality improvement, Sepsis, Sepsis guideline Key Summary Points Why carry out this study? Sepsis guideline implementation—Sepsis management guidelines are intended to support clinicians in delivering optimal care.Country-level insight—The European Sepsis Care Survey (ESCS) provided data on sepsis management guidelines implementation across hospitals in Europe, but presenting country‑specific results can help identify local gaps and guide targeted corrective actions. What did the study ask? Baseline sepsis care evaluation—We examined how optimal is a country‑level baseline sepsis care in hospitals.Detection of deficiencies—We assessed whether deficiencies exist in the diagnosis and treatment of sepsis. What were the study outcomes? Limited use of current definitions—Among Polish hospitals participating in the ESCS, most do not use the up‑to‑date definition of sepsis.Insufficient protocols and training—Only a minority of hospitals have protocols for sepsis recognition and management, as well as training and quality improvement programs.Role of sepsis awareness—Antibiotic stewardship and sepsis monitoring are more common in hospitals with greater sepsis awareness, reflected by the presence of sepsis training programs. What was learned from the study? Low adherence to guidelines—Despite the clinical importance of sepsis, adherence to sepsis guidelines remains low, and substantial deficiencies in sepsis care are evident.Need for national commitment—Improving sepsis care requires country-level commitment, supported by organizational measures and strong institutional leadership. Digital Features This article is published with digital features, including a graphical abstract, to facilitate understanding of the article. To view digital features for this article, go to 10.6084/m9.figshare.32546139. Introduction Sepsis is a life-threatening condition, and a delay in diagnosis and treatment is associated with increased risk of death [1]. The proportion of hospitalized patients affected by sepsis varies across hospitals. A large retrospective analysis of hospital discharge records obtained from the Catalan Health System demonstrated that 1.72% of patients had sepsis diagnoses, with hospital mortality between 19.7% and 23.7% [2]. In US hospitals, an estimate of 6% of patients may have clinical indicators of sepsis, and sepsis is present in up to 35% of patients who die during hospitalization [3]. Early identification of sepsis and timely initiation of appropriate treatment are essential for improving outcomes. This is often challenging due to nonspecific signs and symptoms and the difficult-to-predict course of sepsis, which may rapidly progress to septic shock and death. Successive updates to sepsis definitions and management guidelines aim to support clinicians in delivering optimal care [4–6]. Elements of the complex sepsis care include sepsis screening, sepsis management pathways, diagnostic infrastructure for identifying the source of infection, timely source control, appropriate treatment strategies and monitoring, and quality improvement programs (QIPs), among others [6]. QIPs—encompassing regular training, evaluation of clinical processes, and analysis of outcomes—are critical for effective guideline implementation and for improving sepsis-related results. Sepsis care is strongly influenced by national healthcare structures and policy frameworks; therefore, system-level interventions are essential to ensure that sepsis becomes a strategic priority. Regulatory and organizational initiatives have already demonstrated their effectiveness in improving sepsis outcomes. Examples include the “Sepsis Six” bundle introduced in emergency departments (EDs) in the UK, New York State’s “Rory’s Regulations” mandating hospital-based sepsis protocols, and the Australian and New Zealand Intensive Care Society (ANZICS) Sepsis Breakthrough Collaborative in Australia and New Zealand—all of which have contributed to substantial reductions in sepsis-related mortality [7]. Several EU countries, including Austria, France, Ireland, Italy, Spain, Sweden, and Switzerland, have also incorporated sepsis into national health policies and strategic plans [8]. Presenting the current state of sepsis management may encourage other countries to adopt similar measures. The European Sepsis Care Survey (ESCS) investigated the implementation of sepsis guideline recommendations and the availability of infrastructure for sepsis care in hospitals across Europe, with results published recently [9]. However, findings from a pan-European study—even if concerning—may not receive sufficient attention at the national level. For this reason, we consider it essential to present ESCS data from the perspective of individual countries, enabling targeted corrective actions. Our objective was to provide a country‑level baseline assessment of sepsis care in hospitals and to identify deficiencies in sepsis recognition and management by analyzing ESCS data from centers located in a single country. Methods This study is a post hoc analysis of the ESCS data pertaining to hospitals in Poland. The ESCS study was registered at ClinicalTrials.gov (identifier NCT05059808), and the study protocol received ethical approval from the Ethics Committee of University Medicine Greifswald, Germany (BB 124/21), as well as from the Wroclaw Medical University Bioethics Committee (KB-805/2021). The ESCS study was designed to explore sepsis care in hospitals—primarily in Europe—and included 835 participants from all over Europe between August 2021 and June 2022. The present analysis includes data from 55 hospitals in Poland that participated in the survey. A detailed description of the ESCS methodology is available in the original publication [9]. In brief, hospitals were invited to participate in the survey through national coordinators. Hospitals included in the study were those belonging to the System of Basic Hospital Healthcare Services in Poland, a national network designed to provide comprehensive care for patients with acute conditions. The network comprises 29 university hospitals, 487 regional and district hospitals, and 78 private or independent hospitals, totaling 164,257 acute care beds. All hospitals willing to participate were included; none were excluded. An authorized representative from each hospital willing to participate received a unique link to complete the online survey. The questionnaire addressed sepsis care in emergency departments, general wards and intensive care units (ICU). Items covered sepsis screening, management practices, infrastructure for sepsis care, and the presence of QIPs. Sepsis was defined either as systemic inflammatory response syndrome (SIRS) due to infection (sepsis-1 definition) [10] or as new organ dysfunction caused by infection, evidenced by an increase of ≥ 2 points in the Sequential Organ Failure Assessment (SOFA) score (sepsis-3 definition) [11]. Sepsis screening was defined as a protocol or standardized screening tool specifically for the recognition of sepsis. Screening criteria could include respiratory rate, temperature, mental alteration, heart rate, blood pressure, urine output, lactate, organ dysfunction (mental, cardiovascular, respiratory, renal), biomarkers (procalcitonin, C-reactive protein, interleukin-6), infection (suspected or confirmed), or scores. Sepsis management was defined as a protocol or bundle specifically for the management of sepsis (lactate measurement, blood cultures, antibiotics, crystalloids, vasopressors), and further actions for identification of the source, microbiological sampling, source control, and monitoring, procalcitonin-guided antimicrobial therapy. QIPs were training or programs that included meetings, case reviews, information material and peer-reviews with the aim to improve sepsis quality of care. Survey participants were also asked about monitoring of sepsis cases, sepsis mortality, time to antibiotic administration, adherence to the sepsis treatment bundle, severity of sepsis cases, and number of blood cultures in their hospitals. Statistical Analysis All analyses were performed using Statistica v.13.3 (TIBCO Software Inc., Palo Alto, CA, USA) under license held by the Wroclaw Medical University. Categorical variables are summarized as counts and proportions. Data were analyzed using contingency tables and a Chi-squared test. Significance was assumed if the probability of the null hypothesis was less than 5% (p ≤ 0.05). Missing data were handled using a pairwise deletion approach, meaning that all available data were used for each analysis. Respondents with missing values for specific variables were excluded only from analyses involving those variables. As a result, the number of observations may vary between analyses and tables. Results The System of Basic Hospital Healthcare Services in Poland included 594 hospitals. Of these, 55 hospitals (9.3%) responded to the survey, representing 23,456 acute‑care beds (14.3% of all beds within the network). Of the hospitals, 13 (23.6%) were university hospitals with an average of 783 beds,40 (72.8%) were general hospitals with an average of 345 beds, and 2 (3.6%) were private (independent) hospitals with 260 and 800 beds. In addition, 38 hospitals (69.1%) reported having an emergency department (ED), and 53 (96.4%) reported having an intensive care unit (ICU). The types of wards and ICUs represented in the study are shown in Table 1. Table 1Type of wards and intensive care units in the hospitalsType of wardNumber (N)Surgery23Internal medicine16Intermediate care unit (without ventilation)2Nephrology1Hematology1Transplantology1Urology1Pediatric oncology1Type of intensive care unitNInterdisciplinary41Surgical2Medical3Anesthesiological3Pediatric1 Type of wards and intensive care units in the hospitals Definition and Criteria Used for Sepsis Recognition Sepsis diagnosis was based on sepsis-1 criteria in 51% of hospitals, while sepsis-3 criteria, alone or in combination with sepsis-1, were used in 44%. Sepsis-3 definition, alone or in combination with sepsis-1 criteria, was used more frequently in university hospitals (61%) than in general or independent hospitals (33%), and more often in hospitals with more than 500 beds (71%). However, the overall distribution of the type of sepsis definition used did not differ significantly between university and general/independent hospitals (p = 0.269), and across size categories (p = 0.230) (Table 2). Table 2Sepsis definitions used for identifying sepsis by hospital type and sizeHospital typeDefinition of sepsisSepsis-1Sepsis-3Sepsis-1 AND sepsis-3Other or no definitionp-ValueAll hospitals, N (%)55 (100)28 (51)18 (33)6 (11)3 (5)University13 (24)5 (38)5 (38)3 (23)00.269*General and independent42 (76)25 (59)9 (21)5 (12)3 (7)Number of beds, N (%) ≤ 250 beds20 (36)13 (65)5 (25)1 (5)1 (5)0.230** 251–500 beds18 (33)12 (67)2 (11)3 (17)1 (6) > 500 beds17 (31)4 (24)9 (53)3 (18)1 (6)Sepsis-1—SIRS criteria due to infection. Sepsis-3—new organ failure as evidenced by an increase in SOFA score by ≥ 2 due to infection. “Sepsis-1 AND sepsis-3” means both definitions were used. SIRS systemic inflammatory response syndrome, SOFA Sequential Organ Failure Assessment*p-Value reflects the comparison of the distribution of results between university hospitals and general/independent hospitals**p-Value reflects the comparison of the distribution of results across small, medium, and large hospitals Sepsis definitions used for identifying sepsis by hospital type and size Sepsis-1—SIRS criteria due to infection. Sepsis-3—new organ failure as evidenced by an increase in SOFA score by ≥ 2 due to infection. “Sepsis-1 AND sepsis-3” means both definitions were used. SIRS systemic inflammatory response syndrome, SOFA Sequential Organ Failure Assessment *p-Value reflects the comparison of the distribution of results between university hospitals and general/independent hospitals **p-Value reflects the comparison of the distribution of results across small, medium, and large hospitals Standardized Sepsis Screening for Sepsis Recognition The presence of a protocol or standardized screening tool specifically for the recognition of sepsis was reported in 26.5% (9/34) of emergency departments, 20.5% (8/39) of inpatient wards, and 62.2% (28/45) of intensive care units. Screening criteria used in these departments are presented in Table 3. Table 3Proportion of criteria used for sepsis screening in emergency departments, wards and intensive care units with sepsis screeningEDs, N = 9Wards, N = 8ICUs, N = 28(%)(%)(%)Respiratory rate786375Blood pressure788886Temperature786382Mental alteration677582Heart rate787579Lactate675086Suspected infection1007579C-reactive protein788886Organ dysfunction446389White blood cells786379qSOFA331321Urine output678882Procalcitonin89100100SIRS333854Early warning scores221314SOFA222564Interleukin-6332550ED emergency department, ICU intensive care unit, SOFA Sequential Organ Failure Assessment, qSOFA quick SOFA, SIRS systemic inflammatory response syndrome Proportion of criteria used for sepsis screening in emergency departments, wards and intensive care units with sepsis screening ED emergency department, ICU intensive care unit, SOFA Sequential Organ Failure Assessment, qSOFA quick SOFA, SIRS systemic inflammatory response syndrome Medical emergency teams were present in ten hospitals (18%), with the majority located in university hospitals (80%) and the remainder in general or independent hospitals (20%) (p < 0.001). Standardized Sepsis Management The presence of a protocol for standardized sepsis management was reported by 38.2% (13/34) emergency departments, 30.8% (12/39) wards, and 86.7% (39/45) intensive care units with no significant differences observed between hospitals of different types and sizes (Table 4). Table 4The availability of the standardized protocol for sepsis management in emergency departments, wards, and intensive care units based on the hospital type and the number of hospital bedsAll hospitalUniversityGeneral and independentp-Value0–250 beds251–500 beds> 500 bedsp-ValueN, (%)N, (%)N, (%)N, (%)N, (%)N, (%)EDs13 (38.2)5 (62.5)8 (30.7)0.1164 (36.3)4 (33.3)5 (45.4)0.827Wards12 (30.8)4 (44.4)8 (26.7)0.2685 (31.2)4 (40.0)3 (23.1)0.682ICUs39 (86.7)9 (90.0)30 (85.7)0.59716 (84.2)12 (85.7)11 (91.6)0.819ED emergency department, ICU intensive care unit The availability of the standardized protocol for sepsis management in emergency departments, wards, and intensive care units based on the hospital type and the number of hospital beds ED emergency department, ICU intensive care unit Elements of sepsis management used in hospitals with standardized protocols are shown in Table 5. Table 5Elements of sepsis management reported in hospitals with protocol for standardized sepsis managementInterventionED, N = 13Ward, N = 12ICU, N = 39(%)(%)(%)Surviving sepsis campaign bundleMeasuring lactate level925897Obtaining blood cultures before administration of antibiotics92100100Administering broad-spectrum antibiotics8510097Beginning rapid administration of crystalloidsa928097Applying vasopressors to maintain MAP ≥ 65 mmHgb8593100Organ dysfunctionBlood testingc928397Catheterization/urine output measurement928395SOFA544290Identification of the sourceComputer tomography928397Ultrasound9283100Chest X-ray857597Additional microbiological samplingd928497Source controlInitiation of rapid source control (surgical or interventional)857597MonitoringCentral venous line855097ScVO239872Arterial line62897Passive leg raising or fluid challenge624295Hemodynamic measuremente311795MRSA testing393351ED emergency department, ICU intensive care unit, SOFA sequential organ failure assessment score, ScvO2 central venous oxygen saturation, MRSA methicillin-resistant Staphylococcus aureusaBegin rapid administration of 30 mL/kg of crystalloids for hypotension or lactate ≥ 4 mmol/LbApply vasopressors if patient is hypotensive during or after fluid resuscitation to maintain MAP ≥ 65 mmHgcBy clinical chemistry: white blood cells, coagulation, renal and liver functiondE.g., urine, swabs, cerebrospinal fluideCardiac output, stroke volume, pulse pressure measurement Elements of sepsis management reported in hospitals with protocol for standardized sepsis management ED emergency department, ICU intensive care unit, SOFA sequential organ failure assessment score, ScvO2 central venous oxygen saturation, MRSA methicillin-resistant Staphylococcus aureus aBegin rapid administration of 30 mL/kg of crystalloids for hypotension or lactate ≥ 4 mmol/L bApply vasopressors if patient is hypotensive during or after fluid resuscitation to maintain MAP ≥ 65 mmHg cBy clinical chemistry: white blood cells, coagulation, renal and liver function dE.g., urine, swabs, cerebrospinal fluid eCardiac output, stroke volume, pulse pressure measurement Quality Improvement Programs (QIPs) with the Aim to Improve Sepsis Quality of Care Overall, 37% of respondents reported the presence of any sepsis-related training or QIP (Table 6). However, only 6.6% reported regular sepsis training across all departments. No significant differences were observed by hospital type or size. Table 6Presence of any quality improvement programs, analyzed by hospital type and number of hospital bedsQuality improvement programs, N (%)p valueAll hospitals17 (37.0)University5 (45.5)0.372General and independent12 (34.3)0–250 beds7 (36.8)0.212251–500 beds3 (21.4)> 500 beds7 (53.8)“Quality improvement programs” refer to any initiatives such as training sessions, meetings, case reviews, informational materials, or peer reviews aimed at improving the quality of sepsis care. These programs did not have to be conducted regularly or implemented hospital-wide Presence of any quality improvement programs, analyzed by hospital type and number of hospital beds “Quality improvement programs” refer to any initiatives such as training sessions, meetings, case reviews, informational materials, or peer reviews aimed at improving the quality of sepsis care. These programs did not have to be conducted regularly or implemented hospital-wide QIPs had mostly beneficial effect on sepsis care. In hospitals with any kind of sepsis QIPs, sepsis screening was more common in EDs (33% versus 25%), inpatient wards (27% versus 18%) and ICUs (82% versus 52%), compared with hospitals without QIPs, although the difference was significant only for ICUs (p = 0.048) (Table 7). Table 7Standardized sepsis screening and standardized sepsis management in emergency departments, wards, and intensive care units in hospitals with and without any quality improvement programHospitals without QIP, N (%)Hospitals with any QIP, N (%)p-ValueStandardized sepsis screening EDs5 (25.0)4 (33.3)0.453 Wards4 (17.8)4 (26.6)0.384 ICUs15 (51.7)13 (81.5)0.048Standardized sepsis management EDs7 (35.0)6 (50.0)0.319 Wards7 (30.0)5 (33.0)0.563 ICUs27 (93.1)12 (75.0)0.107ED emergency department, ICU intensive care unit, QIP quality improvement program Standardized sepsis screening and standardized sepsis management in emergency departments, wards, and intensive care units in hospitals with and without any quality improvement program ED emergency department, ICU intensive care unit, QIP quality improvement program Hospitals with any QIP for sepsis were also more likely to implement antibiotic stewardship and antimicrobial use guidelines compared with hospitals without such program (100% versus 59%, p = 0.001, and 71% versus 59%, p = 0.416, respectively), although the difference was not significant for the presence of antimicrobial guidelines (Table 8). Table 8The presence of antibiotic stewardship, antimicrobial guidelines, and monitoring of selected parameters in the management of patients with sepsis in hospitals with and without any quality improvement programsAll hospitalsHospitals without QIPsHospitals with any QIPp-ValueN (%)N (%)N (%)Antibiotic stewardship43 (78.2)17 (58.6)17 (100)0.001Antimicrobial guidelines36 (65.5)17 (58.6)12 (70.6)0.416Monitoring of: Number of sepsis cases25 (54.3)12 (41.4)13 (76.5)0.021 Sepsis mortality18 (39.1)6 (20.7)12 (70.6)0.001 Time-to-antibiotics5 (10.9)0 (0)5 (29.4)0.004 Sepsis bundle compliance6 (13)0 (0)6 (35.3)0.001 Severity of sepsis cases10 (21.7)4 (13.8)6 (35.3)0.092 Number of blood cultures28 (60.9)16 (55.2)12 (70.6)0.236QIP quality improvement program The presence of antibiotic stewardship, antimicrobial guidelines, and monitoring of selected parameters in the management of patients with sepsis in hospitals with and without any quality improvement programs QIP quality improvement program Participants of the survey were asked about selected quality indicators used to monitor the care of patients with sepsis. Sepsis cases and sepsis-related mortality were systematically monitored in 54.3% and 39.1% of hospitals, respectively. Other monitored parameters are listed in Table 8. Sepsis cases, sepsis mortality, time-to-antibiotics, and sepsis bundle compliance were monitored significantly more often in hospitals with sepsis QIPs compared with hospitals without such programs (Table 8). None of the surveyed hospitals reported allocating additional funding specifically for sepsis programs. Finding the Source and Cause of Infection: Access to the Radiological, and Microbiological Investigations Computed tomography (CT) or magnetic resonance imaging (MRI) was available 24 h a day in 94.2% of hospitals. In 5.8% of hospitals CT/MRI was available only in the main working hours. Full-scope microbiological diagnostics were time-limited in most hospitals participating in the study. Microbiological diagnostics, including blood culture incubation, pathogen identification, and notification about blood culture results was available 24 h a day, 7 days a week in only 5.8% of hospitals. Surgical and Interventional Source Control Surgical source control was available 24 h a day in 92.7% of hospitals. Interventional radiology-based source control was available 24/7 in 23.6% of hospitals, and during regular working hours in an additional 10.9%. Fluid Therapy and Hemodynamic Management in ICUs A total of 45 respondents provided information on fluid therapy and hemodynamic management in septic shock patients in the ICU. Balanced crystalloids were used in 98% of ICUs, while 0.9% saline was used in only 9%. Colloid fluids were administered in 38% of ICUs, most commonly albumin (24%), followed by gelatin (16%) and hydroxyethyl starch (11%). Norepinephrine was the first-line catecholamine for septic shock in 98% of ICUs. Fluid resuscitation was guided by hemodynamic monitoring in 93.3% of ICUs, including pulse pressure variation, cardiac output, and stroke volume. Additional guiding methods included response to fluid bolus or passive leg raising (82.2%), central venous pressure (75.6%), echocardiography (60%), and lactate clearance (80%). Point-of-care lactate testing was available in 80% of emergency departments, 11% of wards, and 78% of ICUs. Antimicrobial Therapy: Hospital Guidelines, Antibiotic Stewardship Teams, and Advice on Antibiotic Treatment Hospital guidelines or standard operating procedures for antimicrobial therapy in sepsis were present in 65.5% of hospitals, and 78.2% of hospitals have antibiotic stewardship teams. Advice on antibiotic treatment was available to clinicians in 83% of wards and 86.7% of ICUs. Advice was most commonly provided by: microbiologists (wards 55.3%, ICUs 55.6%), antibiotic stewardship teams (wards 42.6%, ICUs 44.4%), infectious diseases specialists (wards 21.3%, ICUs 22.2%). Anti-infective therapy was guided by procalcitonin in 94.9% of ICUs and in 86.7% of wards. The presence of hospital guidelines for antimicrobial therapy for patients with sepsis and the presence of antibiotic stewardship teams did not differ significantly by hospital type or size. Discussion Sepsis is not easy to diagnose, and delays in treatment are associated with increased mortality. To address this, research has focused on refining sepsis definitions and developing evidence-based guidelines to support early recognition and management of sepsis. It is assumed that compliance with international guidelines ensures optimal treatment of patients diagnosed with sepsis. However, the results of the survey indicate that compliance with current sepsis guidelines in hospitals, both across Europe and in Poland in particular, is not optimal. These findings have important clinical implications, as sepsis continues to pose a major public health burden also in Poland [12]. The definition and conceptual understanding of sepsis have evolved over time and remain the subject of debate [13, 14]. Nevertheless, our study shows that 51% of participating hospitals still rely on the old sepsis-1 criteria, rather than the new sepsis-3 definition. The British National Institute for Health and Care Excellence (NICE) guidelines recommend using clinical parameters to stratify the risk of severe illness or death from sepsis rather than criteria used in the sepsis definitions, as neither the SIRS-based criteria, nor sepsis-3 definition are useful in early identification of those at risk of sepsis [13, 15, 16]. Despite these limitations, multiple studies have demonstrated usefulness of sepsis-3 definition in recognition of sepsis and septic shock in hospital settings [17–20]. Only 27% of EDs, 21% of inpatient wards and 62% of ICUs reported using a sepsis screening protocol. This is even lower than the average rates across European hospitals, which were 54%, 48%, and 62%, respectively [9]. Sepsis screening is a cornerstone of early sepsis recognition and is a number one recommendation in the 2021 Surviving Sepsis Campaign (SSC) guidelines [6]. A recent large randomized trial in Saudi Arabia demonstrated that electronic sepsis screening significantly reduced in-hospital mortality [21]. Vital signs, i.e., heart rate, blood pressure, temperature, and respiratory rate, were commonly used for sepsis screening. In addition, C-reactive protein and procalcitonin levels were used in almost all participating hospitals, despite SSC guidelines suggestion not to rely on procalcitonin levels when initiating antibiotic therapy. Although no single biomarker is universally accepted, both CRP and procalcitonin have demonstrated value in predicting sepsis in patients with suspected infection [22]. A recent meta-analysis confirmed the moderate diagnostic accuracy of procalcitonin and its ability to distinguish bacterial from viral infections [23]. High procalcitonin levels also strongly influence the Food and Drug Adminstration (FDA) authorized Sepsis ImmunoScore algorithm, an artificial-intelligence-based tool for identifying patients at risk of sepsis [24]. Reliance on biomarkers reflects the frequent diagnostic uncertainty surrounding sepsis [22, 25]. Lactate measurement, which is essential for identifying septic shock, was available in only 67% of EDs and 50% of inpatient wards. Hospital medical emergency teams play a crucial role in the early identification and management of deteriorating patients, including those with sepsis. Medical emergency teams were present in only 18% of hospitals in our study, predominantly in university hospitals—a rate far below the 52% reported across Europe. This aligns with previous observations from Poland [26]. Early recognition of clinical deterioration and rapid response are key indicators of care quality, particularly in sepsis. A strong recommendation for using a performance improvement program for sepsis is at the forefront of the 2021 SSC guidelines. A retrospective study from a tertiary care hospital demonstrated that a multimodal sepsis management program reduced readmissions and all-cause mortality, likely due to earlier recognition and treatment [27]. Similarly, New York State’s mandated protocolized sepsis care together with emphasis on continuous quality improvement have reduced sepsis-related mortality [28]. In our study, only one third of hospitals reported any sepsis-related QIP, and regular sepsis training was provided in only very few hospitals. Furthermore, none reported additional funding for sepsis programs. Nevertheless, hospitals with QIPs demonstrated better adherence to key elements of sepsis care, including screening, standardized sepsis management, antibiotic stewardship, antimicrobial guidelines, and monitoring of sepsis cases, mortality, and time-to-antibiotics. Rapid microbiological diagnostics are essential for timely and appropriate antimicrobial therapy. Delays in laboratory processing—often due to limited operating hours—negatively affect outcomes [29]. In one large study, 70% of positive blood cultures flagged outside laboratory working hours [30]. Unfortunately, most clinical microbiology laboratories in Europe are unstaffed during evening and night hours, causing significant delays in processing cultures [29, 31]. The availability of 24/7 clinical microbiology services have beneficial effect on treatment outcome, hospital costs and antibiotic stewardship, helping to control the spread of multiresistant bacteria [32]. Less than 6% of hospitals participating in our study could provide full microbiological diagnostics, including blood culture incubation, pathogen identification and reporting of the results, 24 h a day, 7 days a week. Nearly one quarter relied on external microbiological services, likely reflecting broader trends toward laboratory consolidation and workforce shortages, despite possible concerns about turnaround time, communication, quality control, and infection-control surveillance [33, 34]. Most hospitals had 24/7 access to surgical source control, but interventional radiology was available around the clock in only 23.6% of hospitals, and during working hours in an additional 10.9%. Adequate source control, achieved through both surgical and nonoperative techniques, is a vital component of sepsis management. Effective source control is associated with better outcome, allows for shorter antimicrobial treatment, and prevents the development of antimicrobial resistance [35, 36]. Interventional radiology plays an increasingly important role in early sepsis management [37]. Balanced crystalloids were the preferred fluids for resuscitation in nearly all ICUs, consistent with European data and SSC recommendations. Only 9% used normal saline for this purpose—a trend consistent with the results of the ESCS study conducted in European hospitals [9] and the 2021 SSC guidelines [6]. However, 11% of ICUs reported using hydroxyethyl starch in patients with sepsis, despite clear warnings from the European Medicines Agency and SSC guidelines against its use in sepsis due to serious adverse events [6, 38]. Even more ICUs reported using gelatin in patients with sepsis or septic shock although the 2021 SSC guidelines suggest otherwise [6]. Study Limitations The hospitals included in this study may not fully represent all hospitals in Poland. The sample size was relatively small, limiting generalizability. Participation was voluntary, and responses were self-reported and not independently verified. In summary, results of the survey show that a majority of hospitals do not use an up-to-date definition of sepsis and only a minority of hospitals have protocols for sepsis recognition and management, as well as training and quality improvement programs for sepsis care. Antibiotic stewardship and sepsis monitoring are more common in hospitals with greater sepsis awareness, reflected by the presence of sepsis training programs. Microbiological diagnostics are often time limited, and financial support for sepsis initiatives is lacking. These deficiencies highlight the need for coordinated national efforts to improve sepsis care. Conclusions Overall adherence to current guidelines for timely sepsis recognition and management in hospitals remains low. Hospitals that have implemented structured sepsis quality improvement initiatives demonstrate significantly better compliance with recommended practices. Strengthening performance in this area will require coordinated organizational action supported at the institutional level, including the development of comprehensive sepsis care programs and the systematic use of quality improvement methodologies. Acknowledgements The authors would like to thank the steering committee of the European Sepsis Care Study for their support: Adam Linder, Sweden (Chair of the European Sepsis Alliance Research Working Group); Christian S. Scheer, Germany (Principal investigator); Daniela Filipescu, Romania (Vice-Chair of the European Sepsis Alliance); Evangelos Giamarellos-Bourboulis, Greece (Chair of the European Sepsis Alliance); Evgeny Idelevich, Germany (Representative of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Bloodstream Infections, Endocarditis, and Sepsis); Gabriella Bottari, Italy (Representative European Society of Pediatric and Neonatal Intensive Care); Konrad Reinhart, Germany (Founding president of the Global Sepsis Alliance); Manu LNG Malbrain, Belgium (Representative of the International Fluid Academy); Marlies Ostermann, UK (Representative of the Intensive Care Society); Matthias Gründling, Germany (Quality management project Sepsisdialog Germany); Ricard Ferrer, Spain (Representative of the European Society of Intensive Care Medicine); and Said Laribi, France (Representative of the European Society for Emergency Medicine). Author Contributions Jakub Śmiechowicz conceived the concept of the study and wrote the draft of the manuscript. Jakub Śmiechowicz and Barbara Adamik contributed to the design of the research. All authors (Jakub Śmiechowicz, Christian S. Scheer, Joanna Bartczak, Alicja Bartkowska-Śniatkowska, Katarzyna Baścik, Sławomir L. Czaban, Piotr F. Czempik, Wojciech Dąbrowski, Rafał Gałuszka, Maciej Gawor, Janusz Gruszczyk, Ludmiła Hasak, Jarosław Janc, Mateusz Jaworski, Jarosław Luboński, Małgorzata Mikaszewska-Sokolewicz, Tomasz Musiuk, Piotr Smuszkiewicz, Karina Stefańska-Wronka, Michał Śpiewak, Renata Szmigielska, Mariola Tałałaj, Łukasz Tkaczyk, Witold Wasiak, Rafał Wójtowicz, Magdalena Wujtewicz, Joanna Zorska, and Barbara Adamik) were involved in data collection and interpretation. Jakub Śmiechowicz, Christian S. Scheer, and Barbara Adamik analyzed the data. Barbara Adamik performed statistical analysis. Christian S. Scheer and Barbara Adamik performed a critical revision of the manuscript. All authors provided substantial feedback on the article, reviewed, and approved the final version of the manuscript. Funding No funding or sponsorship was received for this study. The journal’s Rapid Service Fee has been funded by Wroclaw Medical University, Poland, grant number SUBZ.SUBZ.A170.26.056. Data Availability The datasets analyzed during the current study are available from the corresponding author on reasonable request. Declarations Conflict of Interest Jakub Śmiechowicz, Christian S. Scheer, Joanna Bartczak, Alicja Bartkowska-Śniatkowska, Katarzyna Baścik, Sławomir L. Czaban, Piotr F. Czempik, Wojciech Dąbrowski, Rafał Gałuszka, Maciej Gawor, Janusz Gruszczyk, Ludmiła Hasak, Jarosław Janc, Mateusz Jaworski, Jarosław Luboński, Małgorzata Mikaszewska-Sokolewicz, Tomasz Musiuk, Piotr Smuszkiewicz, Karina Stefańska-Wronka, Michał Śpiewak, Renata Szmigielska, Mariola Tałałaj, Łukasz Tkaczyk, Witold Wasiak, Rafał Wójtowicz, Magdalena Wujtewicz, Joanna Zorska, and Barbara Adamik declare that they have no competing interests. Ethical Approval The ESCS study was registered at ClinicalTrials.gov (identifier NCT05059808), and the study protocol received ethical approval from the Ethics Committee of University Medicine Greifswald, Germany (BB 124/21) and from the Wroclaw Medical University Bioethics Committee (KB-805/2021). Footnotes Prior Presentation: Some of the results of this study have been previously presented at a Conference “II Podlaskie Forum Anestezjologiczne,” 5–7 March 2026, Bialowieza, Poland. Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The datasets analyzed during the current study are available from the corresponding author on reasonable request.